Skip to content

Clinical trials

Phase 2 Tobacco Use Disorder trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Tobacco Use Disorder Phase: Phase 2 Country / region: United States Clear all

130 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20026
20035
20045
20057
20066
20074
20087
200914
20104
20114
20128
20135
20145
20153
20165
20171
20186
20193
20204
20214
20224
20233
20244
20253

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed105
Recruiting9
Terminated8
Unknown status3
Withdrawn3
Active, not recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Institute on Drug Abuse (NIDA)20
University of Pennsylvania12
Brown University9
Yale University8
Medical University of South Carolina7
Duke University6
University of Minnesota6
University of Vermont6
National Cancer Institute (NCI)5
Mayo Clinic4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Tobacco Use Disorder130
Alcoholism6
Carcinoma, Non-Small-Cell Lung5
Lung Neoplasms5
Schizophrenia4
Recurrence3
Small Cell Lung Carcinoma3
Alcohol-Related Disorders2
Body Weight2
Carcinoma, Hepatocellular2

Trials

Showing 1 to 25 of 130. Each trial links to its page on Pharma Observatory.

30 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.